WIDE MOAT STOCKS COMPARISON

Checking

 

Stock Comparison

Halma plc vs Thermo Fisher Scientific Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Halma plc

HLMA · London Stock Exchange

Market cap (USD)$17.7B
Gross margin (TTM)—
Operating margin (TTM)20.4%
Net margin (TTM)14.4%
SectorTechnology
IndustryIndustrial conglomerates
CountryGB
Data as of2026-08-23
Insufficient evidence
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Halma plc's moat claims, evidence, and risks.

View HLMA analysis

Thermo Fisher Scientific Inc.

TMO · New York Stock Exchange

Market cap (USD)$266.2B
Gross margin (TTM)41.1%
Operating margin (TTM)17.9%
Net margin (TTM)14.9%
SectorHealthcare
IndustryDiagnostics and life science tools
CountryUS
Data as of2026-08-23
59/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Thermo Fisher Scientific Inc.'s moat claims, evidence, and risks.

View TMO analysis

Comparison highlights

  • Segment focus: Halma plc has 3 segments (40.2% in Environmental & Analysis); Thermo Fisher Scientific Inc. has 4 segments (53.5% in Laboratory Products and Biopharma Services).
  • Moat breadth: Halma plc has 0 moat types across 0 domains; Thermo Fisher Scientific Inc. has 3 across 2.

Primary market context

Halma plc

Environmental & Analysis

Market

Environmental monitoring and analysis instruments (water/resource quality, pollution monitoring) plus materials/optoelectronic analysis and photonics components

Geography

Global

Customer

Utilities and industrial operators; laboratories; OEMs; technology/data-centre customers for photonics components

Role

Instrument OEM / component supplier + solutions provider

Revenue share

40.2%

Thermo Fisher Scientific Inc.

Laboratory Products and Biopharma Services

Market

Laboratory supplies distribution/market channel plus outsourced biopharma services (CDMO/CRO)

Geography

Global

Customer

Pharma & biotech; academic/government labs; industrial and clinical laboratories

Role

Distributor/market channel and outsourced services provider

Revenue share

53.5%

Side-by-side metrics

Halma plc
Thermo Fisher Scientific Inc.
Ticker / Exchange
HLMA - London Stock Exchange
TMO - New York Stock Exchange
Market cap (USD)
$17.7B
$266.2B
Gross margin (TTM)
n/a
41.1%
Operating margin (TTM)
20.4%
17.9%
Net margin (TTM)
14.4%
14.9%
Sector
Technology
Healthcare
Industry
Industrial conglomerates
Diagnostics and life science tools
HQ country
GB
US
Primary segment
Environmental & Analysis
Laboratory Products and Biopharma Services
Market structure
Competitive
Competitive
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
n/a
59 / 100
Moat domains
n/a
Demand, Supply
Last update
2026-09-05
2026-09-05

Moat coverage

Shared moat types

No overlap yet.

Halma plc strengths

No unique moat types yet.

Thermo Fisher Scientific Inc. strengths

Installed Base ConsumablesDistribution ControlProcurement Inertia

Segment mix

Halma plc segments

Full profile >

Safety

Competitive

36.7%

Environmental & Analysis

Competitive

40.2%

Healthcare

Competitive

23.2%

Thermo Fisher Scientific Inc. segments

Full profile >

Life Sciences Solutions

Oligopoly

19.7%

Analytical Instruments

Oligopoly

16.5%

Specialty Diagnostics

Oligopoly

10.3%

Laboratory Products and Biopharma Services

Competitive

53.5%

Act on this comparison

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.